BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 24141785)

  • 1. MicroRNA-9 inhibits the proliferation of oral squamous cell carcinoma cells by suppressing expression of CXCR4 via the Wnt/β-catenin signaling pathway.
    Yu T; Liu K; Wu Y; Fan J; Chen J; Li C; Yang Q; Wang Z
    Oncogene; 2014 Oct; 33(42):5017-27. PubMed ID: 24141785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
    Li GH; Ma ZH; Wang X
    Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-204-5p regulates cell proliferation and metastasis through inhibiting CXCR4 expression in OSCC.
    Wang X; Li F; Zhou X
    Biomed Pharmacother; 2016 Aug; 82():202-7. PubMed ID: 27470356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. microRNA-188 is downregulated in oral squamous cell carcinoma and inhibits proliferation and invasion by targeting SIX1.
    Wang L; Liu H
    Tumour Biol; 2016 Mar; 37(3):4105-13. PubMed ID: 26490981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of squamous cell carcinoma is regulated by miR-139-5p/CXCR4.
    Jiang Q; Cao Y; Qiu Y; Li C; Liu L; Xu G
    Front Biosci (Landmark Ed); 2020 Jun; 25(9):1732-1745. PubMed ID: 32472755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of microRNA 99a in oral squamous cell carcinomas contributes to the growth and survival of oral cancer cells.
    Yan B; Fu Q; Lai L; Tao X; Fei Y; Shen J; Chen Z; Wang Q
    Mol Med Rep; 2012 Sep; 6(3):675-81. PubMed ID: 22751686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of miR-377 Promotes Oral Squamous Cell Carcinoma Growth and Migration by Targeting HDAC9.
    Rastogi B; Kumar A; Raut SK; Panda NK; Rattan V; Joshi N; Khullar M
    Cancer Invest; 2017 Mar; 35(3):152-162. PubMed ID: 28267394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential of tumor-suppressive miR-596 targeting LGALS3BP as a therapeutic agent in oral cancer.
    Endo H; Muramatsu T; Furuta M; Uzawa N; Pimkhaokham A; Amagasa T; Inazawa J; Kozaki K
    Carcinogenesis; 2013 Mar; 34(3):560-9. PubMed ID: 23233740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential involvement of miR-375 in the premalignant progression of oral squamous cell carcinoma mediated via transcription factor KLF5.
    Shi W; Yang J; Li S; Shan X; Liu X; Hua H; Zhao C; Feng Z; Cai Z; Zhang L; Zhou D
    Oncotarget; 2015 Nov; 6(37):40172-85. PubMed ID: 26474386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulated miR329 and miR410 promote the proliferation and invasion of oral squamous cell carcinoma by targeting Wnt-7b.
    Shiah SG; Hsiao JR; Chang WM; Chen YW; Jin YT; Wong TY; Huang JS; Tsai ST; Hsu YM; Chou ST; Yen YC; Jiang SS; Shieh YS; Chang IS; Hsiao M; Chang JY
    Cancer Res; 2014 Dec; 74(24):7560-72. PubMed ID: 25351956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-194 regulated AGK and inhibited cell proliferation of oral squamous cell carcinoma by reducing PI3K-Akt-FoxO3a signaling.
    Chi H
    Biomed Pharmacother; 2015 Apr; 71():53-7. PubMed ID: 25960215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-494 suppresses the progression of breast cancer in vitro by targeting CXCR4 through the Wnt/β-catenin signaling pathway.
    Song L; Liu D; Wang B; He J; Zhang S; Dai Z; Ma X; Wang X
    Oncol Rep; 2015 Jul; 34(1):525-31. PubMed ID: 25955111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis.
    Lin SC; Liu CJ; Lin JA; Chiang WF; Hung PS; Chang KW
    Oral Oncol; 2010 Mar; 46(3):204-8. PubMed ID: 20138800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway.
    Hsieh IS; Chang KC; Tsai YT; Ke JY; Lu PJ; Lee KH; Yeh SD; Hong TM; Chen YL
    Carcinogenesis; 2013 Mar; 34(3):530-8. PubMed ID: 23188675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressive effect of microRNA-126 on oral squamous cell carcinoma in vitro.
    Yang X; Wu H; Ling T
    Mol Med Rep; 2014 Jul; 10(1):125-30. PubMed ID: 24789258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA, TUG1 regulates the oral squamous cell carcinoma progression possibly via interacting with Wnt/β-catenin signaling.
    Liang S; Zhang S; Wang P; Yang C; Shang C; Yang J; Wang J
    Gene; 2017 Apr; 608():49-57. PubMed ID: 28119088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase SHP2 expression.
    Cai Z; Hao XY; Liu FX
    Arch Oral Biol; 2018 May; 89():20-25. PubMed ID: 29407635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-191 regulates oral squamous cell carcinoma cells growth by targeting PLCD1 via the Wnt/β-catenin signaling pathway.
    Wang Z; Guan W; Ma Y; Zhou X; Song G; Wei J; Wang C
    BMC Cancer; 2023 Jul; 23(1):668. PubMed ID: 37460940
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Tang KL; Tang HY; Du Y; Tian T; Xiong SJ
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3278-3285. PubMed ID: 31379206
    [No Abstract]   [Full Text] [Related]  

  • 20. MiR-92a regulates oral squamous cell carcinoma (OSCC) cell growth by targeting FOXP1 expression.
    Guo J; Wen N; Yang S; Guan X; Cang S
    Biomed Pharmacother; 2018 Aug; 104():77-86. PubMed ID: 29772443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.